GcMAF

There are different generations in GcMAF therapy. The first generation GcMAF was developed over 20 years ago. Due to limited testing and clinical use, the efficacy is unknown.

GcMAF (Gc Protein derived Macrophage Activating Factor) Research and references GcMAF

Autism spectrum disorder (ASD) varies in its impact on communication, behavior, and social interaction, requiring tailored support levels. Our clinic offers innovative immunotherapy using GcMAF product, developed in collaboration with Japanese research institutions, to safely enhance ASD symptom management at the cellular level with minimal effort required from patients. The immune system and autism Recently it is becoming clear that immune system dysfunction plays an important role in autism Altered immunity in individuals with autism  Researchers have observed differences in the immune system of individuals with autism, including changes in things like cytokines, immunoglobulins, inflammation and how cells are activated. They have also noticed alterations in various immune cells, such […]